AGP Executive Report
Last update: 11 hours agoEbola Watch (DRC): The Democratic Republic of Congo’s Ebola outbreak has surpassed 6,500 infections and nearly 3,150 deaths, with Ituri still the main hotspot as health authorities report ongoing discharges and high fatality rates—prompting renewed calls to scale up the response. Ebola Treatment Pipeline: A Phase II trial for an oral Ebola drug (NV-387 oral gummies) has been registered in the Pan African Clinical Trials database in the DRC, with local regulatory approval to begin. Sickle Cell Care (Africa): African drugmakers are pushing local production of hydroxyurea and child-friendly formulations to improve access for sickle cell patients, aligning with WHO guidance. Guinea Health & Cooperation: Morocco and Guinea signed 25 cooperation agreements, including deals covering healthcare and other development areas, during their joint commission meeting in Conakry. Public Health Ops (Mosquito Control): A fogging schedule for St John and Christ Church is set to run Sept 7–11, targeting mosquito reduction with evening spraying times. Health, Migration & Care: MSF supported survivors of boat crossings arriving in West Africa, treating severe dehydration, injuries, and infections after days at sea. Animal Health/One Health: The Philippines temporarily banned imports of FMD-susceptible animals and products from multiple countries including Guinea, citing lab-confirmed outbreaks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.